# Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE

> **NCT03581877** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Northwell Health** · enrollment: 31 (actual)

## Conditions studied

- Pulmonary Embolism
- Pulmonary Hypertension
- Thromboembolism
- Right Ventricular Dysfunction

## Interventions

- **DRUG:** Alteplase
- **DEVICE:** EKOS

## Key facts

- **NCT ID:** NCT03581877
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-01-28
- **Primary completion:** 2023-03-19
- **Final completion:** 2025-03-19
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2024-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03581877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03581877, "Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03581877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*